Author

L. Sun

OpenAlex ID: A5013286355

First-in-human trial of a poly(ADP-ribose) polymerase (PARP) inhibitor MK-4827 in advanced cancer patients (pts) with antitumor activity in BRCA-deficient and sporadic ovarian cancers.

2010 · S. K. Sandhu, R. M. Wenham, et al. · Journal of Clinical Oncology · 34

Works count: 1

Citation count: 34

H-index: 1

I10-index: 1